12.100
−13,57%
2025-12-29
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -276.7% | -74.7% | 1 / 3 | +61.8% | +15.97 pp | -3.40 pp | -9.0% | 0.04 | — | 16,5 | +61,8% | −1,0 | −276,7% | — | -6.21 | — |
| Pts | 0 | 0 | 4 | 12 | 12 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 12.100 (close price on 2025-12-29)EPS (TTM): −871,5
Financial charts
1.Revenue & growth
VND bn16,5Q2/26
1.Revenue & growth
VND bn16,5Q2/26
2.Profit & growth
VND bn-0,98Q2/26
3.Profit mix (Penman)
VND bn-17,0Q2/26
4.Margins & cost structure
%18.1%Q2/26
5.Returns & cash cycle
% · days-12.0%Q2/26
6.Earnings quality & cash
VND bn-45,6Q2/26
7.Asset structure
VND bn237Q2/26
8.Funding & debt health
VND bn · times237Q2/26
9.Revenue backlog
VND bn0,89Q2/26
10.Valuation
times · %-13,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-49Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
175%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26